Abdominal Compression for Orthostatic Hypotension
Trial Summary
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. However, since the study involves comparing abdominal compression with the standard medication midodrine, it's possible that you may need to continue or adjust your current treatment. Please consult with the trial coordinators for specific guidance.
What data supports the effectiveness of the treatment Abdominal Compression for Orthostatic Hypotension?
Is abdominal compression safe for humans?
How does the treatment of abdominal compression for orthostatic hypotension differ from other treatments?
Abdominal compression, such as using an elastic abdominal binder or an inflatable bladder, is unique because it directly targets the splanchnic veins in the abdomen to prevent blood pooling when standing, unlike traditional drugs like midodrine that increase blood pressure through other mechanisms. This non-drug approach can be activated only when needed, providing a flexible and immediate response to changes in posture.13567
What is the purpose of this trial?
Compression garments have been shown to be effective in the treatment of orthostatic hypotension in autonomic failure patients. The purpose of this study is to determine the hemodynamic mechanisms by which abdominal compression (up to 40 mm Hg) improve the standing blood pressure and orthostatic tolerance in these patients, and to compare them with those of the standard of care midodrine. The investigators will test the hypothesis that abdominal compression will blunt the exaggerated fall in stroke volume and the increase in abdominal vascular volume during head up tilt.
Research Team
Italo Biaggioni, MD
Principal Investigator
Vanderbilt University
Luis E Okamoto, MD
Principal Investigator
Vanderbilt University Medical Center
Eligibility Criteria
This trial is for adults aged 18-80 with neurogenic orthostatic hypotension due to autonomic failure (like Parkinson's or Multiple System Atrophy). Participants must have a significant drop in blood pressure upon standing. Pregnant individuals, those with major heart, liver, kidney issues, recent severe cardiovascular events, or conditions that could interfere with the study can't join.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants undergo head up tilt testing with abdominal compression and sham compression in a randomized, crossover fashion
Follow-up
Participants are monitored for changes in systolic blood pressure, splanchnic vascular volume, and stroke volume during head up tilt
Treatment Details
Interventions
- Abdominal compression
- midodrine
- Placebo pill
- Sham abdominal compression
Find a Clinic Near You
Who Is Running the Clinical Trial?
Vanderbilt University Medical Center
Lead Sponsor
National Heart, Lung, and Blood Institute (NHLBI)
Collaborator